0001576280-21-000108.txt : 20211123 0001576280-21-000108.hdr.sgml : 20211123 20211123190702 ACCESSION NUMBER: 0001576280-21-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211119 FILED AS OF DATE: 20211123 DATE AS OF CHANGE: 20211123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talasaz AmirAli CENTRAL INDEX KEY: 0001753159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 211440598 MAIL ADDRESS: STREET 1: 18 ISABELLA AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_163771240170350.xml FORM 4 X0306 4 2021-11-19 0 0001576280 Guardant Health, Inc. GH 0001753159 Talasaz AmirAli 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 1 0 0 Co-Chief Executive Officer COMMON STOCK 2021-11-19 4 P 0 37721 97.8225 A 1787066 D COMMON STOCK 2021-11-19 4 P 0 12279 98.7848 A 1799345 D COMMON STOCK 2021-11-23 4 P 0 6033 92.4199 A 1805378 D COMMON STOCK 2021-11-23 4 P 0 23467 93.0514 A 1828845 D COMMON STOCK 2021-11-23 4 P 0 5000 94 A 1833845 D COMMON STOCK 2021-11-23 4 P 0 5000 95.50 A 1838845 D COMMON STOCK 2021-11-23 4 P 0 14900 96.8305 A 1853745 D COMMON STOCK 2021-11-23 4 P 0 100 98 A 1853845 D COMMON STOCK 470800 I Shares held by Talasaz Investments, L.P. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.64 to $98.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.75 to $99.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.885 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.915 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. /s/ John Saia, as attorney-in-fact for AmirAli Talasaz 2021-11-23